The Efavirenz (EFV) Central Nervous System Exposure Sub-study of Encore1
Clinical trial NCT01451333 · COMPLETED
Trial details
- NCT number
- NCT01451333
- Sponsor
- Kirby Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-10-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.